BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32861716)

  • 1. T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort.
    Pastori D; Carnevale R; Stanzione R; Nocella C; Cotugno M; Marchitti S; Bianchi F; Forte M; Valenti V; Biondi-Zoccai G; Schiavon S; Vecchio D; Versaci F; Frati G; Violi F; Volpe M; Pignatelli P; Rubattu S; Sciarretta S
    Int J Cardiol; 2021 Jan; 322():245-249. PubMed ID: 32861716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients.
    Rubattu S; De Giusti M; Farcomeni A; Abbolito S; Comito F; Cangianiello S; Greco ES; Dito E; Pagliaro B; Cotugno M; Stanzione R; Marchitti S; Bianchi F; Di Castro S; Battistoni A; Burocchi S; Caprinozzi M; Pierelli G; Sciarretta S; Volpe M
    J Cardiovasc Med (Hagerstown); 2016 Aug; 17(8):601-7. PubMed ID: 25252038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases.
    Rubattu S; Sciarretta S; Marchitti S; Bianchi F; Forte M; Volpe M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling.
    Sciarretta S; Marchitti S; Bianchi F; Moyes A; Barbato E; Di Castro S; Stanzione R; Cotugno M; Castello L; Calvieri C; Eberini I; Sadoshima J; Hobbs AJ; Volpe M; Rubattu S
    Circ Res; 2013 May; 112(10):1355-64. PubMed ID: 23529183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
    Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
    JAMA; 2008 Jan; 299(3):296-307. PubMed ID: 18212314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
    Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
    Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide T2238C gene polymorphism and the risk of cardiovascular diseases: A meta‑analysis.
    Wang J; Yang Y; Zheng M; Zhang L; Wulasihan M
    Biomed Rep; 2024 Mar; 20(3):41. PubMed ID: 38357235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family History of Atrial Fibrillation and Risk of Cardiovascular Events: A Multicenter Prospective Cohort Study.
    Pastori D; Menichelli D; Lip GYH; Sciacqua A; Violi F; Pignatelli P;
    Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008477. PubMed ID: 32718257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.
    Carnevale R; Pignatelli P; Frati G; Nocella C; Stanzione R; Pastori D; Marchitti S; Valenti V; Santulli M; Barbato E; Strisciuglio T; Schirone L; Vecchione C; Violi F; Volpe M; Rubattu S; Sciarretta S
    Sci Rep; 2017 Jun; 7(1):3797. PubMed ID: 28630469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-specific ischemic complications in elderly patients with atrial fibrillation: Data from the prospective ATHERO-AF study.
    Pastori D; Menichelli D; Bucci T; Violi F; Pignatelli P;
    Int J Cancer; 2020 Dec; 147(12):3424-3430. PubMed ID: 32588421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.
    Pastori D; Pignatelli P; Menichelli D; Violi F; Lip GYH
    Mayo Clin Proc; 2019 Jul; 94(7):1261-1267. PubMed ID: 30551910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro.
    Stanzione R; Sciarretta S; Marchitti S; Bianchi F; Di Castro S; Scarpino S; Cotugno M; Frati G; Volpe M; Rubattu S
    Cell Death Dis; 2015 Dec; 6(12):e2033. PubMed ID: 26720342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events.
    Carnevale R; Nocella C; Pignatelli P; Bartimoccia S; Stefanini L; Basili S; Novo M; D'Amico A; Cammisotto V; Pastori D; Violi F
    Atherosclerosis; 2018 Jul; 274():29-34. PubMed ID: 29747088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
    Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
    Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study.
    Menichelli D; Sciacqua A; Cangemi R; Andreozzi P; Del Sole F; Violi F; Pignatelli P; Pastori D;
    Int J Clin Pract; 2021 Mar; 75(3):e13771. PubMed ID: 33078565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation.
    Tuinenburg AE; Brundel BJ; Van Gelder IC; Henning RH; Van Den Berg MP; Driessen C; Grandjean JG; Van Gilst WH; Crijns HJ
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):827-35. PubMed ID: 10376920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
    Pastori D; Nocella C; Farcomeni A; Bartimoccia S; Santulli M; Vasaturo F; Carnevale R; Menichelli D; Violi F; Pignatelli P;
    J Am Coll Cardiol; 2017 Sep; 70(12):1455-1462. PubMed ID: 28911508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
    Pastori D; Pignatelli P; Sciacqua A; Perticone M; Violi F; Lip GYH
    Int J Cardiol; 2018 Mar; 255():69-73. PubMed ID: 29290420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in
    Cheng C; Liu H; Tan C; Tong D; Zhao Y; Liu X; Si W; Wang L; Liang L; Li J; Wang C; Chen Q; Du Y; Wang QK; Ren X
    FASEB J; 2019 Aug; 33(8):8878-8891. PubMed ID: 31034774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro.
    Scarpino S; Marchitti S; Stanzione R; Evangelista A; Di Castro S; Savoia C; Quarta G; Sciarretta S; Ruco L; Volpe M; Rubattu S
    J Hypertens; 2009 Sep; 27(9):1804-13. PubMed ID: 19702001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.